☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Lyell Immunopharma
Lyell Immunopharma’s LYL845 Receives the US FDA’s Orphan Drug Designation to Treat Melanoma
November 10, 2023
Load more...
Back to Home